$PRTA News Article - Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022 https://marketwirenews.com/news-releases/prot...00890.html
My Twitter: WhyteStocks